1. Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD;
2. Intramural Clinical Management and Operations Branch, SAIC, Frederick, MD;
3. Paediatric Immunology Unit, Newcastle General Hospital, Newcastle, United Kingdom;
4. National Cancer Institute (NCI) Laboratory of Pathology, NIH, Bethesda, MD;
5. NCI Cancer Biomarkers Research Group, Bethesda, MD;
6. SAIC, Frederick, MD;
7. Dermatology Branch, NCI, NIH, Bethesda, MD;
8. Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT; and
9. Laboratory of Cell Biology, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Bethesda, MD